Evidence map›Paper›PMID 29748384›Full record

ArticleThe Journal of biological chemistry2018

Balance between senescence and apoptosis is regulated by telomere damage-induced association between p16 and caspase-3.

Shanmugam Panneer Selvam, Braden M Roth, Rose Nganga, Jisun Kim, Marion A Cooley, Kristi Helke, Charles D Smith, Besim Ogretmen

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Cell Proliferation and Apoptosis-Key Players in the Lung Aging Process.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Effects ofThe Journal of international medical research · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Shanmugam Panneer SelvamFrom the Department of Biochemistry and Molecular Biology.
Braden M RothFrom the Department of Biochemistry and Molecular Biology.ORCID 0000-0001-7559-7671
Rose NgangaFrom the Department of Biochemistry and Molecular Biology.
Jisun KimFrom the Department of Biochemistry and Molecular Biology.
Marion A CooleyDepartments of Regenerative Medicine and.
Kristi HelkeComparative Medicine, Medical University of South Carolina, Charleston, South Carolina 30912 and.
Charles D Smiththe Department of Pharmacology, Pennsylvania State University, Hershey, Pennsylvania 17033.
Besim OgretmenFrom the Department of Biochemistry and Molecular Biology, ogretmen@musc.edu.ORCID 0000-0002-1019-5660
Medical University of South Carolina · USPennsylvania State University · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI John J Lemasters · 2009 to 2026
$42.7M
Project 3: Targeting SK2/S1P Signaling for the Regulation of c-Myc and Tumor SuppressionP01CA203628 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OGRETMEN, BESIM · 2016 to 2021
$8.9M
Ceramide Signaling in the Regulation of Head & Neck Cancer Cell Death and TherapyR01DE016572 · NIDCR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OGRETMEN, BESIM · 2005 to 2025
$7.4M
RESEARCH PILOT PROJECTS PROGRAMP30GM103339 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OGRETMEN, BESIM · 2012 to 2016
$5.4M
Regulation of Telomerase by Sphingolipid Signaling in Lung CancerR01CA088932 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OGRETMEN, BESIM · 2002 to 2017
$3.3M
Research Supplement to Promote Diversity in Health-Related ResearchR01CA214461 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Besim Ogretmen · 2018 to 2026
$3.3M
MUSC FACIL EXPANSION &RENOV: SLE C06RR015455 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CROUCH, ROSALIE K · 2002 to 2002
$2.0M
Mechanisms of sphingolipid analogue drug FTY720-mediated NSCLC tumor suppressionR01CA173687 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OGRETMEN, BESIM · 2013 to 2017
$1.5M
NCI NIH HHS P01 CA203628NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA088932NCI NIH HHS R01 CA173687NCI NIH HHS R01 CA214461NCRR NIH HHS C06 RR015455NIDCR NIH HHS R01 DE016572NIGMS NIH HHS P30 GM103339
6 · The paper itself

Abstract

Telomerase activation protects cells from telomere damage by delaying senescence and inducing cell immortalization, whereas telomerase inhibition mediates rapid senescence or apoptosis. However, the cellular mechanisms that determine telomere damage-dependent senescence

Indexed as

ApoptosisCellular SenescenceAnimalsCaspase 3Cell ProliferationCyclin-Dependent Kinase Inhibitor p16FemaleHumansLung NeoplasmsLysophospholipidsMiceMice, KnockoutMice, SCIDPhosphotransferases (Alcohol Group Acceptor)SphingosineSphingosine KinaseCaspase 3Cyclin-Dependent Kinase Inhibitor p16LysophospholipidsPhosphotransferases (Alcohol Group Acceptor)Sphingosinesphingosine 1-phosphateSphingosine Kinasesphingosine kinase 2, humansphingosine kinase 2, mouseapoptosissenescencesignal transductionsphingolipidsphingosine-1-phosphate (S1P)telomerase reverse transcriptase (TERT)

Identifiers

PMID29748384
PMCPMC6016453
OpenAlexW2801632433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.